Author:
Spadaccio Cristiano,Nappi Francesco,De Marco Federico,Sedati Pietro,Taffon Chiara,Nenna Antonio,Crescenzi Anna,Chello Massimo,Trombetta Marcella,Gambardella Ivancarmine,Rainer Alberto
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine
Reference71 articles.
1. Frangogiannis, N. G. (2004). Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflammation Research, 53(11), 585–595.
2. Chamberlain, D. A. (1987). Overview of completed sudden death trials: European experience. Cardiology, 74(Suppl 2), 10–23.
3. Demirovic, J., & Myerburg, R. J. (1994). Epidemiology of sudden coronary death: an overview. Progress in Cardiovascular Diseases, 37(1), 39–48.
4. Myerburg, R. J., Kessler, K. M., & Castellanos, A. (1992). Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation, 85(1 Suppl), I2–10.
5. Kang, H. J., Kim, H. S., Koo, B. K., et al. (2007). Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial. Am Heart J, 153(2), 237 e231–238, doi: 10.1016/j.ahj.2006.11.004 .
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献